Risedronate Sodium
Risedronate sodium delayed-release tablets are a bisphosphonate in a delayed-release formulation and is indicated for treatment of postmenopausal osteoporosis (1.1) Limitations of Use…
Risedronate sodium delayed-release tablets are a bisphosphonate in a delayed-release formulation and is indicated for treatment of postmenopausal osteoporosis (1.1) Limitations of Use…
Risedronate sodium tablet USP is a bisphosphonate indicated for: Treatment and prevention of postmenopausal osteoporosis (1.1) Treatment to increase bone mass in men with osteoporosis (1…
Risedronate sodium is a bisphosphonate indicated for: Treatment and prevention of postmenopausal osteoporosis (1.1) Treatment to increase bone mass in men with osteoporosis (1.2)…
NDC 70771-1436-4 in blister-carton of 4 (1 x 4) Unit-dose Tablets. Risedronate Sodium Delayed-release Tablets, 35 mg. R x only 4 Tablets Risedronate Sodium DR Tablets, 35 mg. Risedronate…
Risedronate sodium tablets are bisphosphonate indicated for: Treatment and prevention of postmenopausal osteoporosis (1.1) Treatment to increase bone mass in men with…
This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.
Privacy Policy | Copyright © 2024. All Rights Reserved.